-+ 0.00%
-+ 0.00%
-+ 0.00%

REIN THERAPEUTICS DOSES FIRST PATIENT IN PHASE 2 TRIAL OF LTI-03 FOR IDIOPATHIC PULMONARY FIBROSIS

Reuters·03/03/2026 13:00:06

Please log in to view news